# |
Date discussed |
Author |
Title |
Journal |
date |
Relevant finding
|
1. |
2010-02-19 |
McKee |
Varenicline reduces alcohol self-administration in heavy-drinking smokers |
Biol Psych |
2009 |
|
2. |
2010-02-19 |
Ericson |
The smoking cessation medication Varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system |
JPET |
2009 |
microdialysis shows that nicotine+alcohol induces more dopamine than either alone
|
3. |
2010-02-19 |
Kamens |
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice |
Psychopharm |
2010 |
|
4. |
2010-02-26 |
Miyoshi |
Quantitative Analysis of Peripheral Benzodiazepine Receptor in the Human Brain Using PET with 11C-AC-5216 |
JNM |
2009 |
|
5. |
2010-02-26 |
Folkersma |
Reference Tissue Models and Blood–Brain Barrier Disruption: Lessons from (R)-[11C]PK11195 in Traumatic Brain Injury |
JNM |
2009 |
|
6. |
2010-03-05 |
Coe |
Varenicline: An a4b2 Nicotinic Receptor Partial Agonist for Smoking Cessation |
J Med Chem |
2005 |
|
7. |
2010-03-05 |
Reperant |
Effect of the a4b2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in b2 knock-out mice with selective re-expression of the b2 subunit in the ventral tegmental area |
Neuropharm |
2010 |
|
8. |
2010-03-12 |
Barrett |
The Hedonic Response to Cigarette Smoking Is Proportional to Dopamine Release in the Human Striatum as Measured by Positron Emission Tomography and 11C-Raclopride |
Synapse |
2004 |
|
9. |
2010-03-12 |
Brody |
Smoking-Induced Ventral Striatum Dopamine Release |
A J Psychiatry |
2004 |
|
10. |
2010-03-19 |
Rollema |
Rationale, pharmacology and clinical efficacy of partial agonists of a4b2 nACh receptors for smoking cessation |
TIPS |
2007 |
This is the one I MEANT to post earlier. Take a look!
|
11. |
2010-03-19 |
Converse |
PET Measurement of rCBF in the presence of a neurochemical tracer |
J Neurosci Meth |
2004 |
|
12. |
2010-03-19 |
Sziraki |
The Effect of Cotinine on Nicotine- and Cocaine-Induced Dopamine Release in the Nucleus Accumbens |
Neurochem Res |
1999 |
look at Figure 3!
|
13. |
2010-04-09 |
Perkins |
Medication screening for smoking cessation: a proposal for new methodologies |
Psychopharm |
2006 |
|
14. |
2010-04-09 |
McKee |
Developing human laboratory models of smoking lapse behavior for medication screening |
Addict Biol |
2009 |
Do we want to use the priming drink (see fig 3)
|
15. |
2010-04-23 |
Jackson |
Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse |
Psychopharm |
2010 |
|
16. |
2010-04-23 |
Scott |
Smoking Modulation of mu-Opioid and Dopamine D2 Receptor-Mediated Neurotransmission in Humans |
Neuropsychopharm |
2007 |
|
17. |
2010-04-30 |
Janes |
Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence |
Biol Psychiatry |
2010 |
look at measures of abstinence
|
18. |
2010-05-07 |
Janhunen |
The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats |
N-S Arch Pharm |
2005 |
look at microdial w/ mecamylamine and nicotine
|
19. |
2010-05-07 |
Hahn |
Kappa-opioid receptor modulation of nicotine-induced behaviour |
Neuropharm |
2000 |
look at measures effect of norBNI on nicotine-induced movement
|
20. |
2010-06-11 |
Koob and Volkow |
Neurocircuitry of Addiction |
Neuropsychopharm |
2010 |
|
21. |
2010-06-11 |
Fowler et al |
Fast uptake and long-lasting binding of methamphetamine in the human brain: compariosn with cocaine |
NeuroImage |
2008 |
|
22. |
2010-06-18 |
Edgerton et al |
Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An 11C-raclopride PET study |
NeuroImage |
2010 |
|
23. |
2010-06-25 |
Porrino et al |
The effects of cocaine: A shifting target over the course of addiction |
Progress in Neuro-Psychopharmacology & Biological Psychiatry |
2007 |
|
24. |
2010-06-25 |
London et al |
Cocaine-Induced Reduction of Glucose Utilization in Human Brain |
Aerch Gen Psychiatry |
1990 |
|
25. |
2010-07-09 |
Fuente-Fernandez et al |
Visualizing vesicular dopamine dynamics in Parkinson`s disease |
Synapse |
2009 |
|
26. |
2010-07-09 |
Yokochi |
[https://tauruspet.med.yale.edu/staff/edm42/papers/summer-journal-club/levodopa-for-PD-review-Yokochi-PRD2009.pdf Reevaluation of levodopa therapy for the treatment of advanced Parkinson`s disease |
Parkinsonism and Related Disorders ] |
2009 |
|
27. |
2010-07-09 |
Fuente-Fernandez et al |
VMAT2 Binding Is Elevated in Dopa-Responsive Dystonia: Visualizing Empty Vesicles by PET |
Synapse |
2003 |
|
28. |
2010-07-16 |
Morgan et al |
Social Dominance in Monkeys: Dopamine D2 Receptors and Cocaine Self-Administration |
Nature Neuroscience |
2002 |
could be relevant to Jenna's data
|
29. |
2010-08-06 |
Opacka-Juffry et al |
Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET |
J Neural transmission |
1998 |
could be relevant to our PD project; Irina, take note!
|
30. |
2010-08-13 |
Brody et al |
Smoking-induced change in intrasynaptic dopamine concentration: Effect of treatment for Tobacco Dependence |
Psychiatry Reseaerch: Neuroimaging |
2010 |
Did they scoop us ?! Aiiieeegghhhhh ... you be the judge!
|
31. |
2010-08-27 |
Perkins et al |
Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans |
Clin Pharm and Therapeutics |
2010 |
I think these gals and their approach to medications testing are our main competition. We have to prove to people that PET is a real biomarker of drug efficacy!
|
32. |
2010-10-08 |
Burger et al |
Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5 |
J Nucl Med |
2010 |
|
33. |
2010-10-15 |
Volkow et al |
The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects. |
Biol Psych |
2005 |
|
34. |
2010-10-15 |
Volkow, Fowler et al |
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain |
JAMA |
2009 |
|
35. |
2010-10-22 |
Carter et al |
Drug-Induced Impulse Control Disorders: A Prospectus for Neuroethical Analysis |
Neuroethics |
2010 |
|
36. |
2010-11-16 |
Rilling et al |
Neural Correlates of Maternal Separation in Rhesus Monkeys |
Biological Psychiatry |
2001 |
|
37. |
2010-11-16 |
Blaizot et al |
Mapping the Visual Recognition Memory Network With PET in the Behaving Baboon |
JCBFM |
2000 |
|
38. |
2010-12-10 |
Marota et al |
Cocaine Activation Discriminates Dopaminergic Projections by Temporal Response: An fMRI Study in Rat |
Neuroimage |
2000 |
guess we did not invent peak-time-maps
|
39. |
2010-12-17 |
Yoder et al |
Test-Retest Variability of 11C-Raclopride Binding Potential in Nontreatment-Seeking Alcoholics |
Synapse |
2010 |
|
40. |
2011-01-14 |
Egerton et al |
Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An 11C-raclopride PET study |
Neuroimage |
2010 |
this is a repeat - may have relevance to Jenna's cocaine data, also introduces tasks to heighten effect of drug
|
##. |
2011-01-14 |
Brody et al |
Redo of #30, above |
Psych Res neuroimag |
2009 |
lets reconsider figure 1, which I believe is mislabeled
|
41. |
2011-01-14 |
Montgomery et al |
The Effect of Nicotine on Striatal Dopamine Release in Man: A 11C-raclopride PET Study |
Synapse |
2007 |
|
42. |
2011-01-14 |
Takahashi et al |
Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study |
Int J Neurpsychopharm |
2008 |
|